Molecular Cancer
Overview
Molecular Cancer is a peer-reviewed journal that focuses on the molecular basis of cancer development and progression. It publishes cutting-edge research articles, reviews, and commentaries that explore the intricate mechanisms underlying tumor biology, including genetic and epigenetic alterations, signaling pathways, and therapeutic strategies. With a multidisciplinary approach, Molecular Cancer provides valuable insights into the molecular complexities of cancer, fostering advancements in diagnosis, treatment, and prevention.
Details
Details
Abbr.
Mol Cancer
Publisher
Biomed Central
Start
2002
End
Continuing
e-ISSN
1476-4598
Country
United Kingdom
Language
English
Specialties
Oncology
Molecular Biology
Molecular Biology
Metrics
Metrics
h-index / Ranks: 754
196
SJR / Ranks: 108
8222
CiteScore / Ranks: 24
64.90
JIF / Ranks: 55
37.3
Recent Articles
11.
Peng M, Zhang S, Wu P, Hou X, Wang D, Ge J, et al.
Mol Cancer
. 2025 Mar;
24(1):67.
PMID: 40050914
Background: Circular RNAs (circRNAs), characterized by their covalently closed-loop structures, constitute a distinct class of non-coding RNAs. They play pivotal regulatory roles within cells and are intricately associated with the...
12.
Raut P, Mathivanan P, Batra S, Ponnusamy M
Mol Cancer
. 2025 Mar;
24(1):70.
PMID: 40050874
The mutation in Gsα-coding GNAS exons, popular as gsp oncogene, is the most frequent mutation across all heterotrimeric G proteins involved in oncogenesis. GNAS R201, the most frequently mutated, followed...
13.
Appidi T, China D, Stefan G, Moreau M, Mao S, Velarde E, et al.
Mol Cancer
. 2025 Mar;
24(1):68.
PMID: 40050802
Clinical cancer treatment modalities include radiation as one of the first-line therapies used for treating almost two-thirds of cancer patients. Combinational therapy for cancer is becoming extremely popular, with multiple...
14.
Ji Y, Xiao C, Fan T, Deng Z, Wang D, Cai W, et al.
Mol Cancer
. 2025 Mar;
24(1):66.
PMID: 40038722
Targeting the dysregulation of epigenetic mechanisms in cancer has emerged as a promising therapeutic strategy. Although the significant rationale progress of epigenetic therapies in blocking cancer cells, how epigenetic regulation...
15.
Li X, Kim H, Yoo J, Lee Y, Nam C, Park J, et al.
Mol Cancer
. 2025 Mar;
24(1):64.
PMID: 40033380
Glioblastoma (GBM) is the most aggressive and common type of primary malignant brain cancer in adults. GBM often recurs locally near the resection cavity (RC) following the surgical removal of...
16.
Maksymova L, Pilger Y, Nuhn L, Van Ginderachter J
Mol Cancer
. 2025 Mar;
24(1):65.
PMID: 40033293
Among the emerging strategies for cancer theranostics, nanomedicines offer significant promise in advancing both patients' diagnosis and treatment. In combination with nanobodies, nanomedicines can potentially enhance the precision and efficiency...
17.
Xu X, Su J, Zhu R, Li K, Zhao X, Fan J, et al.
Mol Cancer
. 2025 Mar;
24(1):63.
PMID: 40033282
High-resolution three-dimensional (3D) tissue analysis has emerged as a transformative innovation in the life sciences, providing detailed insights into the spatial organization and molecular composition of biological tissues. This review...
18.
Wang F, Wang C, Chen S, Wei C, Ji J, Liu Y, et al.
Mol Cancer
. 2025 Mar;
24(1):60.
PMID: 40025576
Background: Cancer remains a leading global cause of mortality, making early detection crucial for improving survival outcomes. The study aims to develop a machine learning-enabled blood-derived exosomal RNA profiling platform...
19.
Chong S, Lu J, Valentin R, Lehmberg T, Eu J, Wang J, et al.
Mol Cancer
. 2025 Mar;
24(1):62.
PMID: 40025512
Background: Established genetic biomarkers in chronic lymphocytic leukemia (CLL) have been useful in predicting response to chemoimmunotherapy but are less predictive of response to targeted therapies. With several such targeted...
20.
Wan M, Pan S, Shan B, Diao H, Jin H, Wang Z, et al.
Mol Cancer
. 2025 Mar;
24(1):61.
PMID: 40025508
Aberrant lipid metabolism is a well-recognized hallmark of cancer. Notably, breast cancer (BC) arises from a lipid-rich microenvironment and depends significantly on lipid metabolic reprogramming to fulfill its developmental requirements....